EHA-SWG Scientific Meeting on Challenges in the Diagnosis and Management of Myeloproliferative Neoplasms
Dates: October 12-14, 2017
Location: Budapest, Hungary
Chairs: C Harrison, JJ Kiladjian
EHA and the EHA Scientific Working Group on Myeloproliferative Neoplasms are organizing this EHA-SWG Scientific Meeting on Challenges in the Diagnosis and Management of Myeloproliferative Neoplasms.
Below you can find key information and the links to important further details regarding registration and accommodation and a wide array of sponsor opportunities available for pharmaceutical companies.
The scientific program will cover the following topics:
- Molecular pathogenesis and diagnosis
- State of the art: Novel therapies for MPN
- Indolent MPN
- What’s new in myelofibrosis?
- Use of interferon in MPN
- Mechanisms of resistance to JAK inhibitors
- Patient advocacy in EU
- Prognostic scores in MPN
- Advances in systemic mastocytosis
- Advances in diagnosis and management of CMML
- State of the art: investigation and management of erythrocytosis
The meeting will take place at the Novotel Budapest City
Alkotás u. 63
1123 Budapest, Hungary
This meeting is supported by:
For support opportunities click here.
EBAH CME Accreditation
Continuing Medical Education (CME) is widely accepted as a means to encourage individual practitioners to maintain and develop professional knowledge and skills keeping up-to-date with latest developments within the field. The meeting will be accredited by the EBAH system. Participants of this meeting are eligible to receive one Continuing Medical Education (CME) credit point for every hour of accredited activity from the EBAH system.